Cargando…
The sonic hedgehog factor Gli1 imparts drug resistance through inducible glucuronidation
Autores principales: | Zahreddine, Hiba Ahmad, Culjkovic-Kraljacic, Biljana, Assouline, Sarit, Gendron, Patrick, Romeo, Andrea A., Morris, Stephen J., Cormack, Gregory, Jaquith, James B., Cerchietti, Leandro, Cocolakis, Eftihia, Amri, Abdellatif, Bergeron, Julie, Leber, Brian, Becker, Michael W., Pei, Shanshan, Jordan, Craig T., Miller, Wilson H., Borden, Katherine L.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138053/ https://www.ncbi.nlm.nih.gov/pubmed/24870236 http://dx.doi.org/10.1038/nature13283 |
Ejemplares similares
-
Sonic Hedgehog factor Gli1: As good as resistant
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2015) -
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine
por: Assouline, Sarit, et al.
Publicado: (2023) -
The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012) -
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2017) -
eIF4E3, a new actor in mRNA metabolism and tumor suppression
por: Volpon, Laurent, et al.
Publicado: (2013)